Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Disappearance of Slan-Positive Non-Classical Monocytes As a New Parameter for the Diagnosis of Chronic Myelomonocytic Leukemia with Associated Inflammatory State

Sihem Tarfi, PharmD, Bouchra Badaoui, PharmD, Nicolas Freynet, PharmD, Margot Morabito, Jeffie Lafosse, Andrea Toma, MD PhD, Pierre Fenaux, MD PhD, Eric Solary, MD PhD, Dorothée Selimoglu-Buet, PhD, Orianne Wagner Ballon, MD PhD

Blood (2018) 132 (Supplement 1): 4376.

https://doi.org/10.1182/blood-2018-99-116451

Published: 2018

Journal Articles

Red Blood Cell Lysis Procedure Improves the Performances of ELN Dyserythropoiesis Score Compared to Nuclear Dye Use without Lysis

Hugo Germain, Sihem Tarfi, PharmD, Nicolas Freynet, PharmD, Andrea Toma, MD PhD, Bouchra Badaoui, PharmD, Orianne Wagner Ballon, MD PhD

Blood (2018) 132 (Supplement 1): 3108.

https://doi.org/10.1182/blood-2018-99-114179

Published: 2018

Journal Articles

A Randomized Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS: Gfm's 'pick a Winner' Trial

Blood (2018) 132 (Supplement 1): 467.

https://doi.org/10.1182/blood-2018-99-111756

Published: 2018

Journal Articles

Lenalidomide-Mediated Erythroid Improvement in Non-Del(5q) Myelodysplastic Syndromes Is Associated with Bone Marrow Immuno-Remodeling

Gwenneg Kerdivel, PhD, Virginie Chesnais, PhD, Etienne Becht, PhD, Andrea Toma, MD PhD, Nicolas Cagnard, PhD, Florent Dumont, PhD, Alice Rousseau, Pierre Fenaux, MD PhD, Sylvie Chevret, MD PhD, Nicolas Chapuis, PharmD, PhD, Valentina Boeva, PhD, Wolf-Herman Fridman, Olivier Kosmider, Michaela Fontenay, MD PhD

Blood (2017) 130 (Supplement 1): 2983.

https://doi.org/10.1182/blood.V130.Suppl_1.2983.2983

Published: 2017

Journal Articles

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Blood (2017) 130 (Supplement 1): 1705.

https://doi.org/10.1182/blood.V130.Suppl_1.1705.1705

Published: 2017

Journal Articles

Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML

Dorothée Selimoglu-Buet, Bouchra Badaoui, Emmanuel Benayoun, Andréa Toma, Pierre Fenaux, Bruno Quesnel, Gabriel Etienne, Thorsten Braun, Nassera Abermil, Margot Morabito, Nathalie Droin, Eric Solary, Orianne Wagner-Ballon

Blood (2017) 130 (6): 832–835.

https://doi.org/10.1182/blood-2017-04-779579

Published: 2017

Journal Articles

Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion

Virginie Chesnais, Aline Renneville, Andrea Toma, Jérôme Lambert, Marie Passet, Florent Dumont, Sylvie Chevret, Julie Lejeune, Anna Raimbault, Aspasia Stamatoullas, Christian Rose, Odile Beyne-Rauzy, Jacques Delaunay, Eric Solary, Pierre Fenaux, François Dreyfus, Claude Preudhomme, Olivier Kosmider, Michaela Fontenay

Blood (2016) 127 (6): 749–760.

https://doi.org/10.1182/blood-2015-04-640128

Published: 2016

Includes: Supplemental data

Journal Articles

Outcome of Lower Risk Non Del 5q MDS after Failure of Erythropoiesis Stimulating Agents (ESA), and Impact of Post-ESA Treatment on Survival: A Retrospective European Study

Blood (2015) 126 (23): 1665.

https://doi.org/10.1182/blood.V126.23.1665.1665

Published: 2015

Journal Articles

NPM1 Expression Level and a CRBN Polymorphism Are Able to Predict the Rate of Response to Lenalidomide in Non Del(5q) Lower Risk MDS Patients Resistant to Erythropoiesis-Stimulating Agents: The GFM Experience

Virginie Chesnais, Aline Renneville, Andrea Toma, Veronique Sardnal, Marie Passet, Audrey Gauthier, Jacques Delaunay, MD, Aspasia Stamatoulas, MD, Odile Beyne-Rauzy, MDPhD, Pierre Fenaux, MD PhD, Francois Dreyfus, MD, Claude Preudhomme, PharmD, PhD, Olivier Kosmider, MD PhD, Michaela Fontenay

Blood (2014) 124 (21): 533.

https://doi.org/10.1182/blood.V124.21.533.533

Published: 2014

Journal Articles

Lenalidomide (LEN) Combined To Intensive Chemotherapy (IC) In AML and Higher Risk MDS With Del 5q. Results Of a Phase I/II Study Of The Groupe Francophone Des Myelodysplasies (GFM)

Lionel Ades, Thomas Prebet, MD PhD, Aspasia Stamatoullas, Christian Recher, MD PhD, Romain Guieze, MD, Emmanuel Raffoux, Krimo Bouabdallah, MD, Mathilde Hunault, Eric Wattel, Laure Stalnikiewicz, MD, Andrea Toma, Herve Dombret, MD, PhD, Norbert Vey, MD PhD, Claude Gardin, MD, Benedicte Samey, Sylvie Chevret, Pierre Fenaux, MD, PhD

Blood (2013) 122 (21): 620.

https://doi.org/10.1182/blood.V122.21.620.620

Published: 2013

Journal Articles

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial

Blood (2011) 118 (14): 3824–3831.

https://doi.org/10.1182/blood-2011-05-352039

Published: 2011

Includes: Supplemental data

Journal Articles

Lenalidomide (LEN) Combined to Intensive Chemotherapy (IC) In AML and Higher Risk MDS with Del 5q. Results of a Phase I/II Study of the Groupe Francophone Des Myelodysplasies (GFM)

Lionel Ades, Thomas Prebet, M.D., Ph.D., Aspasia Stamatoullas, Christian Recher, MD, PhD, Romain Guieze, Emmanuel Raffoux, Krimo Bouabdallah, Mathilde Hunault, Eric Wattel, Laure Stalnikiewicz, Andrea Toma, Herve Dombret, MD, Norbert Vey, Simone Boehrer, Claude Gardin, Pierre Fenaux, MD, PhD

Blood (2010) 116 (21): 508.

https://doi.org/10.1182/blood.V116.21.508.508

Published: 2010

Journal Articles

Immunophenotypic Analysis Using CD80 and CD86 Staining Improves the Diagnosis of Waldenstrom's Macroglobulinemia by Evidencing a CD80+/CD86- Profile.

Andrea Toma, MD, PhD, Stephanie Poulain, MD, Aurore Grelier, Magali Le Garff-Tavernier, MD, Frederic Davi, Pr, Martine Brissard, Patrick Bonnemye, Stephanie Gueguen, Lucille Musset, MD, Nabih Azar, MD, Pierre Morel, MD, Xavier Leleu, Veronique Leblond, Helene Merle-Beral, Pr

Blood (2009) 114 (22): 4389.

https://doi.org/10.1182/blood.V114.22.4389.4389

Published: 2009

Journal Articles

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

Andrea Toma, Marie-Lorraine Balère-Appert, Jean-Michel Boiron, MD, Pierre Bordigoni, Pr, Gerard Socie, MD, PhD, Jean-Paul Vernant, Pr, Marc Renaud, MD, Noel Milpied, MD, PhD, Mauricette Michallet, MD, PhD, Eric Deconinck, Pr, Denis Guyotat, MD, PhD, Frederic Garban, MD, Anne Sirvent, MD, Nathalie Contentin, MD, Didier Blaise, Pr, Evelyne Marry, Agnes Buzyn, Pr

Blood (2009) 114 (22): 873.

https://doi.org/10.1182/blood.V114.22.873.873

Published: 2009

Journal Articles

New Immunophenotypic Profile of Waldenstrom’s Macroglobulinemia: Interest of CD80 and CD86 Staining

Andrea Toma, Magali Le Garff-Tavernier, Martine Brissard, Patrick Bonnemye, Lucille Musset, Nabih Azar, Veronique Leblond, Helene Merle-Beral

Blood (2008) 112 (11): 5277.

https://doi.org/10.1182/blood.V112.11.5277.5277

Published: 2008

Journal Articles

Immunophenotypic Analysis of Waldenstrom’s Macroglobulinemia: A Study of 63 Cases.

Andrea Toma, Magali Le Garff-Tavernier, Martine Brissard, Patrick Bonnemye, Lucile Musset, Nabih Azar, Veronique Leblond, Helene Merle-Beral

Blood (2007) 110 (11): 4399.

https://doi.org/10.1182/blood.V110.11.4399.4399

Published: 2007

Journal Articles

Impact of HLA Allele Mismatch on the Outcome of Patients with Reduced-Intensity Allogeneic Haematopoietic Stem Cell Transplantation from Unrelated Donors: Analysis of 103 Patients of the French Registry.

Andrea Toma, Marie-Lorraine Balere-Appert, Zina Chir, Jean-Michel Boiron, Pierre Bordigoni, Gerard Socie, Jean-Paul Vernant, Marc Renaud, Noel-Jean Milpied, Mauricette Michallet, Eric Deconninck, Denis Guyotat, Frederic Garban, Anne Sirvent, Nathalie Contentin, Didier Blaise, Colette Raffoux, Agnes Buzyn

Blood (2006) 108 (11): 3149.

https://doi.org/10.1182/blood.V108.11.3149.3149

Published: 2006

NARROW

Disappearance of Slan-Positive Non-Classical Monocytes As a New Parameter for the Diagnosis of Chronic Myelomonocytic Leukemia with Associated Inflammatory State

Red Blood Cell Lysis Procedure Improves the Performances of ELN Dyserythropoiesis Score Compared to Nuclear Dye Use without Lysis

A Randomized Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS: Gfm's 'pick a Winner' Trial

Lenalidomide-Mediated Erythroid Improvement in Non-Del(5q) Myelodysplastic Syndromes Is Associated with Bone Marrow Immuno-Remodeling

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML

Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion

Outcome of Lower Risk Non Del 5q MDS after Failure of Erythropoiesis Stimulating Agents (ESA), and Impact of Post-ESA Treatment on Survival: A Retrospective European Study

NPM1 Expression Level and a CRBN Polymorphism Are Able to Predict the Rate of Response to Lenalidomide in Non Del(5q) Lower Risk MDS Patients Resistant to Erythropoiesis-Stimulating Agents: The GFM Experience

Lenalidomide (LEN) Combined To Intensive Chemotherapy (IC) In AML and Higher Risk MDS With Del 5q. Results Of a Phase I/II Study Of The Groupe Francophone Des Myelodysplasies (GFM)

Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial

Lenalidomide (LEN) Combined to Intensive Chemotherapy (IC) In AML and Higher Risk MDS with Del 5q. Results of a Phase I/II Study of the Groupe Francophone Des Myelodysplasies (GFM)

Immunophenotypic Analysis Using CD80 and CD86 Staining Improves the Diagnosis of Waldenstrom's Macroglobulinemia by Evidencing a CD80+/CD86- Profile.

The Use of Bone Marrow Graft for Hematopoietic Stem Cell Transplantation From Matched Unrelated Donors After Reduced Intensity Conditioning Regimen Improves Survival : Analysis of the Societe Française De Greffe De Moelle Et De Therapie Cellulaire.

New Immunophenotypic Profile of Waldenstrom’s Macroglobulinemia: Interest of CD80 and CD86 Staining

Immunophenotypic Analysis of Waldenstrom’s Macroglobulinemia: A Study of 63 Cases.

Impact of HLA Allele Mismatch on the Outcome of Patients with Reduced-Intensity Allogeneic Haematopoietic Stem Cell Transplantation from Unrelated Donors: Analysis of 103 Patients of the French Registry.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only